Biochemical analysis showed that IL-6 and TNF-α levels were within normal ranges in the groups treated with PRP and PRP + ropivacaine, whereas these levels remained elevated in the untreated disc degeneration groups, indicating ongoing effects of degeneration. The gene discussed is IL6; the disease is intervertebral disk degenerative disorder.